A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ... Elife 6, e28482, 2017 | 68 | 2017 |
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer MK Bakht, Y Yamada, SY Ku, VB Venkadakrishnan, JA Korsen, ... Nature cancer 4 (5), 699-715, 2023 | 32 | 2023 |
Novel insights in cell cycle dysregulation during prostate cancer progression S Ben-Salem, VB Venkadakrishnan, HV Heemers Endocrine-related cancer 28 (6), R141-R155, 2021 | 25 | 2021 |
Polymeric black tea polyphenols (PBPs) inhibit benzo (a) pyrene and 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone‐induced lung carcinogenesis potentially through down … RR Hudlikar, VB Venkadakrishnan, R Kumar, RA Thorat, S Kannan, ... Molecular carcinogenesis 56 (2), 625-640, 2017 | 25 | 2017 |
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells MK Bakht, JJ Hayward, F Shahbazi-Raz, M Skubal, R Tamura, KF Stringer, ... Proceedings of the National Academy of Sciences 119 (4), e2025710119, 2022 | 15 | 2022 |
AR-dependent phosphorylation and phospho-proteome targets in prostate cancer VB Venkadakrishnan, S Ben-Salem, HV Heemers Endocrine-related cancer 27 (6), R193-R210, 2020 | 12 | 2020 |
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy VB Venkadakrishnan, AD DePriest, S Kumari, D Senapati, S Ben-Salem, ... Oncogene 38 (23), 4496-4511, 2019 | 11 | 2019 |
Diversity in androgen receptor action among treatment-naïve prostate cancers is reflected in treatment response predictions and molecular subtypes S Ben-Salem, Q Hu, Y Liu, M Alshalalfa, X Zhao, I Wang, ... European urology open science 22, 34-44, 2020 | 9 | 2020 |
Significance of RB loss in unlocking phenotypic plasticity in advanced cancers VB Venkadakrishnan, Y Yamada, K Weng, O Idahor, H Beltran Molecular Cancer Research 21 (6), 497-510, 2023 | 4 | 2023 |
Prostate cancer progression relies on the mitotic kinase citron kinase C Rawat, S Ben-Salem, N Singh, G Chauhan, A Rabljenovic, V Vaghela, ... Cancer Research 83 (24), 4142-4160, 2023 | 3 | 2023 |
CHD1 promotes sensitivity to aurora kinase inhibitors by suppressing interaction of AURKA with its coactivator TPX2 H Li, Y Wang, K Lin, VB Venkadakrishnan, M Bakht, W Shi, C Meng, ... Cancer research 82 (17), 3088-3101, 2022 | 3 | 2022 |
Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ... Elife 6, e33738, 2017 | 2 | 2017 |
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer Y Yamada, VB Venkadakrishnan, K Mizuno, M Bakht, SY Ku, MM Garcia, ... Science Translational Medicine 15 (722), eadf6732, 2023 | 1 | 2023 |
Genomic alterations impact cell cycle-related genes during prostate cancer progression S Ben-Salem, VB Venkadakrishnan, HV Heemers Endocrine-related cancer 28 (6), L5-L10, 2021 | 1 | 2021 |
Erratum: Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer (eLife (2017) 6 PII: e33738) S Liu, S Kumari, Q Hu, D Senapati, VB Venkadakrishnan, D Wang, ... eLife 6, 2017 | 1 | 2017 |
Chemoprevention of lung cancer by polymeric black tea polyphenols (PBPs): Preclinical evaluation of potential molecular targets R Hudlikar, V Venkadakrishnan, R Kaushal, R Thorat, S Kannan, A Ingle, ... EUROPEAN JOURNAL OF CANCER 54, S69-S69, 2016 | 1 | 2016 |
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes VB Venkadakrishnan, AG Presser, R Singh, MA Booker, NA Traphagen, ... | | 2024 |
SAT633 The RNA Helicase UPF1 Mediates AR-And SRF-dependent Transcription In Prostate Cancer G Chauhan, VB Venkadakrishnan, U Dahiya, Y Ghanem, GJ Srinivasan, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 2203, 2023 | | 2023 |
Abstract A015: Citron kinase is a novel driver of prostate cancer progression and controls alternative splicing associated with treatment-resistance C Rawat, N Singh, G Chauhan, A Rabljenovic, S Ben-Salem, V Vaghela, ... Cancer Research 83 (11_Supplement), A015-A015, 2023 | | 2023 |
Abstract B017: Lineage-specific PRC2 targets and response to EZH2 inhibition in neuroendocrine prostate cancer VB Venkadakrishnan, R Singh, Y Yamada, K Mizuno, AG Presser, SY Ku, ... Cancer Research 83 (11_Supplement), B017-B017, 2023 | | 2023 |